Schedule 13D ownership disclosure

ENZON INC

Security class unavailable · CUSIP: 293904108

Event date: 2016-11-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,319,777
Percent of class
2.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000928464-16-000246
Form type
SC 13D/A
Filer
ENZON PHARMACEUTICALS, INC.
CIK
CIK 727510
Filed
Nov 29, 2016
Reporting period
Nov 28, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub